Pharmafile Logo
Pharmafocus logo
Advanced Search
Aubagio image

NICE recommends Aubagio

January 22, 2014
Sales and Marketing Aubagio, EU, FDA, NICE, Sanofi, gilenya

NICE has recommended Genzyme’s multiple sclerosis pill Aubagio for use on the NHS. In final guidance the watchdog said Aubagio …

News

EU regulator recommended 81 medicines in 2013

January 21, 2014
CHMP, EC, EU, FDA, US, rare diseases

Last year the Committee for Medicinal Products for Human Use (CHMP) recommended 81 medicines for marketing approval, compared with just …

News
Emergent image

Emergent plans to triple anthrax vaccine production

January 21, 2014
Manufacturing and Production Emergent BioSolutions, FDA, anthrax, biothrax

Emergent BioSolutions is planning a major expansion of manufacturing capacity for its anthrax vaccine BioThrax to meet the biodefense objectives …

News
Biocon image

Herceptin biosimilar set for Indian market

January 21, 2014
Research and Development, Sales and Marketing Biocon, Herceptin, Roche, biosimilars, canmab

Biocon has said its generic version of Roche’s ageing breast cancer drug Herceptin will go on sale in India from …

News
Abbvie image

AbbVie advances oncology drug

January 21, 2014
Research and Development, Sales and Marketing AbbVie, DNA, oncology, veliparib

AbbVie has begun a Phase III trial of its investigational compound veliparib in women with early-stage, triple-negative breast cancer.  This …

News
Roche image

Roche schizophrenia drug fails

January 21, 2014
Research and Development, Sales and Marketing Roche, biopertin, schizophrenia

Roche’s investigational schizophrenia drug bitopertin has failed to help patients with the disorder’s negative symptoms when pitted against placebo. Two …

News

Manufacturing news in brief

January 21, 2014
Manufacturing and Production BASF, Heidelberg CSAT, Markem-Imaje, SEPIPROD and Micro-Sphere/NanoMaterials Technology, SPL, Shenzhen Hepalink

Shenzhen Hepalink buys SPL and Markem-Imaje takes over Heidelberg CSAT, plus a new science park in the UK and updates …

News
screen_shot_2014-01-21_at_08

Novasep adds president to complete its executive team

January 21, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Nieuwenhove, Novasep

Thierry Van Nieuwenhove has joined contract manufacturing organisation Novasep as president of its Synthesis business unit. Educated as a bio-engineer, Van …

Appointment
aurobindo image

Actavis makes Aurobindo sale

January 21, 2014
Sales and Marketing Actavis, Aurobindo, India, generics

Actavis is to sell its commercial operations in seven European countries to Aurobindo Pharma in a bid to put more …

News

Government sugar tsar works for Coca-Cola and Mars

January 20, 2014
Sales and Marketing UK government, action on sugar, macdonald

It has been revealed that the man tasked by the UK government to help implement tougher regulation on sugar levels …

News
Ranbaxy image

Ranbaxy quality issues hit sixth plant; seeks Diovan workaround

January 20, 2014
Manufacturing and Production FDA, Ranbaxy, fines, manufacturing

Yet another plant operated by India’s Ranbaxy has been held up by US Food and Drug Administration over quality deficiencies, …

News
Merck image

Merck recalls Liptruzet on packaging defects

January 20, 2014
Manufacturing and Production FDA, Merck, US, liptruzet, recall

Merck & Co has been forced to undertake a massive recall of its combination cholesterol-lowering drug Liptruzet in the US …

News
J&J image

J&J to sell division for $4.1 billion

January 20, 2014
Sales and Marketing Diagnostics, J&J, JJ, carlyle, ocd, ortho-clinical

Johnson & Johnson has been offered $4.15 billion by private equity firm The Carlyle Group to buy its Ortho-Clinical Diagnostics …

News
Shire image

Shire sheds Dermagraft at $650m loss

January 20, 2014
Sales and Marketing Organogenesis, Shire, dermagraft

Shire has offloaded its Dermagraft business to Organogenesis just three years after purchasing the company. Given the sale has come …

News
Social media image

Problems and solutions

January 20, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing adams, culture, pharma, problems, social media

Not long ago I was asked to be involved in a project that filmed UK-based pharma journalists in order to …

Feature
thomas

New chair for British Generic Manufacturers Association

January 20, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing bgma, thomas broeer

Thomas Broeer has been elected as chair of 





The British Generic Manufacturers Association (BGMA). Broeer, managing director of Kent Pharmaceuticals, …

Appointment

Europe nod for Gilead HCV pill

January 20, 2014
Sales and Marketing FDA, Gilead, HCV, hep C, sofosbuvir, sovaldi

Gilead Sciences’ once-daily, oral hepatitis C treatment Sovaldi has been given the green light by the European Commission, just a …

News
Google lens image

Google to use contact lens as diabetes monitor

January 17, 2014
Medical Communications, Sales and Marketing calico, contact, diabetes, google, lens

Google is developing a new type of contact lens designed to help patients with diabetes measure their blood sugar levels. …

News
China image

Actavis: China is ‘too risky’

January 17, 2014
Sales and Marketing Actavis, China, bribery, generics, risky

The boss of generic drug manufacturer Actavis says his company is pulling out of China because the business environment there …

News

Technology to dominate 2014 for businesses

January 17, 2014
Medical Communications 2014, Cloud Computing, IT, digital, e-zest, technology

2014 will see healthcare businesses and governments rapidly absorb new technologies in order to enhance user experience and foster innovation …

News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026